SCHEMBL19166007

SCHEMBL19166007

c1ccc(-c2cc(-c3ccc(-c4ccncn4)cc3)nc(-c3cc(-c4ccc5oc6ccccc6c5c4)cc(-c4ccc5oc6ccccc6c5c4)c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.37
▸ PLA2G4A P47712 3/20 0.37
▸ PLA2G10 O15496 1/20 0.37
▸ MAPT P10636 5/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ MAPK13 O15264 2/20 0.35
▸ MAPK12 P53778 2/20 0.35
▸ MAPK11 Q15759 2/20 0.35
▸ MAPK14 Q16539 2/20 0.35
▸ RAF1 P04049 1/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ ACP1 P24666 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19165331 0.97 MEN1 (0.38) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165838 0.97 MEN1 (0.38) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165885 0.95 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165369 0.88 KMT2A (0.40) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165806 0.88 DHODH (0.42) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL15501578 0.88 KMT2A (0.45) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165798 0.87 MEN1 (0.41) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL19165167 0.87 HSD17B10 (0.44) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL15501485 0.87 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10MAPTNPC1
SCHEMBL15501690 0.87 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-22 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback